News
Curated oncology headlines from reputable sources, ranked by importance with Claude Opus 5.
News about: Hodgkin Lymphoma (HL) → cancer profile · × Clear filters
Classic Hodgkin Lymphoma: A Review
JAMA published a comprehensive review summarizing current evidence on the pathogenesis, epidemiology, diagnosis, and management of classic Hodgkin lymphoma in adults aged 18 years and older. The article synthesizes the evolving treatment landscape, including risk-adapted therapy and newer agents, within the context of established clinical practice. It serves as a reference consolidation rather tha…
Phase 3 EuroNet-PHL-LP1: complete resection alone gives 79.5% five-year event-free survival in paediatric early-stage nodular lymphocyte-predominant Hodgkin lymphoma
In the prospective phase 3 EuroNet-PHL-LP1 trial, patients under 18 with stage IA/IIA nodular lymphocyte-predominant Hodgkin lymphoma who underwent complete lymph node resection followed by active surveillance had a five-year event-free survival of 79.5% (78 of 247 eligible patients). Those with unresectable disease received three cycles of anthracycline-free CVP chemotherapy, with good outcomes i…
Local AI agent brings tumor board expertise to hematological malignancies
Nature Cancer reports a locally deployed AI agent, running on a hospital's own infrastructure, intended to reproduce the work of a multidisciplinary tumour board in haematological malignancies. Local deployment means patient data never leave the institution, which is the main advantage claimed over cloud-based systems. The available report does not state how many cases were assessed, how the syste…